Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

astrazeneca spa - budesonide - capsule - "3 mg capsule rigide a rilascio modificato" 50 capsule

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

stallergenes ag - niccoli sulfas, alcoholes adipis lanae, neomycini sulfas, kalii dichromas, benzocainum, cinchocaini hydrochloridum, tetracaini hydrochloridum, amylis cinnamaldehydum, isoeugenolum, cinnamaldehydum, eugenolum, alcohol cinnamylicus, hydroxycitronellalum, geraniolum, evernia prunastri, colophonium, e 218, e 214, propylis parahydroxybenzoas, butylis parahydroxybenzoas, benzylis parahydroxybenzoas, balsamum peruvianum, ethylendiamini dihydrochloridum, cobalti dichloridum, resina p-tert-butylphenoli formaldehydi, epoxy resina, diphenylguanidinum, zinci diethyldithiocarbamas, zinci dibutyldithiocarbamas, isopropylphenyl-para-phenylendiaminum, cyclohexylphenyl-para-phenylendiaminum, diphenyl-para-phenylendiaminum, methylchloroisothiazolinonum, methylisothiazolinonum, quaternium-15, methyldibromoglutaronitrilum, para-phenylendiaminum, formaldehydum, morpholinylmercaptobenzothiazolum, cyclohexylbenzothiazylis sulfenamidum, dibenzothiazylis disulfidum, thiomersalum, tetramethylthiuramum monosulfidum, thiramum, disulfiramum, dipentamethylenis thiurami disulfidum, diazolidinylureum, clioquinolum, chlorquinaldolum, tixocortoli pivalas, natrii aurothiosulfas dihydricus, imidazolidinylureum, budesonidum, hydrocortisoni-17 butyras, mercaptobenzothiazolum, bacitracinum, parthenolidum, caeruleum dispersatum 106, bronopolum - cerotti - tela cum praeparatione (panel 1): niccoli sulfas 0.16 mg, hydroxypropylcellulosum, alcoholes adipis lanae 0.81 mg, povidonum, neomycini sulfas 0.49 mg, povidonum, kalii dichromas 0.044 mg, povidonum, cain-mix: benzocainum 0.364 mg, cinchocaini hydrochloridum 0.073 mg, tetracaini hydrochloridum 0.073 mg, povidonum, parfum-mix: amylis cinnamaldehydum 0.015 mg, isoeugenolum 0.015 mg, cinnamaldehydum 0.034 mg, eugenolum 0.034 mg, alcohol cinnamylicus 0.054 mg, hydroxycitronellalum 0.054 mg, geraniolum 0.070 mg, evernia prunastri 0.070 mg, hydroxypropylcellulosum, betadexum, colophonium 0.97 mg, povidonum, e 320 0.011 mg, e 321 0.011 mg, paraben-mix: e 218 0.16 mg, e 214 0.16 mg, propylis parahydroxybenzoas 0.16 mg, butylis parahydroxybenzoas 0.16 mg, benzylis parahydroxybenzoas 0.16 mg, povidonum, balsamum peruvianum 0.65 mg, povidonum, ethylendiamini dihydrochloridum 0.041 mg, povidonum, cobalti dichloridum 0.016 mg, hydroxypropylcellulosum, polyesterum, ethyleni et vinylis acetatis polymerisatum, acrylic adhesive, pro praeparatione. tela cum praeparatione (panel 2): resina p-tert-butylphenoli formaldehydi 0.036 mg, hydroxypropylcellulosum, epoxy resina 0.041 mg, hydroxypropylcellulosum, carba-mix: diphenylguanidinum 0.068 mg, zinci diethyldithiocarbamas 0.068 mg, zinci dibutyldithiocarbamas 0.068 mg, hydroxypropylcellulosum, schwarzgummi-mix: isopropylphenyl-para-phenylendiaminum 0.010 mg, cyclohexylphenyl-para-phenylendiaminum 0.025 mg, diphenyl-para-phenylendiaminum 0.025 mg, povidonum, methyl(chlor)isothiazolinon: methylchloroisothiazolinonum 0.0024 mg, methylisothiazolinonum 0.00081 mg, povidonum, quaternium-15 0.081 mg, hydroxypropylcellulosum, methyldibromoglutaronitrilum 0.0041 mg, povidonum, para-phenylendiaminum 0.065 mg, povidonum, formaldehydum 0.15 mg ut hydroxymethylis succinimidum, natrii carbonas, natrii hydrogenocarbonas, povidonum, mercapto-mix: morpholinylmercaptobenzothiazolum 0.020 mg, cyclohexylbenzothiazylis sulfenamidum 0.020 mg, dibenzothiazyli - la diagnosi delle allergie - allergeni: prodotto diagnostico

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

biofutura pharma spa - budesonide - polvere per inalazione - 200 mcg 120 capsule polvere per inalazione in blister con inalatore

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

biofutura pharma spa - budesonide - polvere per inalazione - 400 mcg 60 capsule polvere per inalazione in blister con inalatore